InGell Labs BV
Pharmaceuticals - Groningen, Groningen, Netherlands
InGell Labs BV Employees
InGell Labs BV Details
InGell Labs BV (IGL – Groningen, The Netherlands) is an SME which develops injectable drug-depots for slow release of a broad range of therapeutic actives, all based on its patent-protected InGell®-platforms, and with rapid access to scale-up for cGMP processing. Applications are done with major Pharma companies in Diabetes, Pain management, OA, and CNS. Public-Private partnerships exist in orthopaedic, veterinary and oncology applications with UU-UMCU-UMCG-LUMC and UTwente. The company has developed two different polymer-based drug delivery platforms: InGell®-Gamma (hydrogel-depots) and InGell®-LQP (pure polymer depots). The platforms offer injectable drug delivery depots, which are formulated and delivered as liquids through thin needles (up to 31G).
InGell Labs BV Technologies
Email Providers
Outlook
Load Balancers
Apache
Fonts
Google Font API
Tag Management
Google Tag Manager
Other
Microsoft Office 365